Picture of Brainsway logo

BWAY — Brainsway News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Refile: Israel's BrainsWay Q2 revenue rises 35% to record high on higher shipments, utilization

REFILE-Israel's BrainsWay Q2 revenue rises 35% to record high on higher shipments, utilization

Adds contact and disclaimer details at end of story

-
Overview

  • Israel neurostimulation device maker's Q2 revenue grew 35% yr/yr to record level

  • Adjusted EBITDA for Q2 more than doubled yr/yr, margin expanded to 20%

  • Company raised full-year 2026 revenue and EBITDA guidance


Outlook

  • BrainsWay raises FY 2026 revenue guidance to $68 mln-$70 mln from $66 mln-$68 mln

  • Company lifts FY 2026 adjusted EBITDA outlook to $13 mln-$14 mln from $12 mln-$14 mln

  • BrainsWay expects FY 2026 operating income margin of 13.5%-14%


Result Drivers

  • RECORD SYSTEM SHIPMENTS - Co shipped a record 125 Deep TMS systems in Q2, up 42% yr/yr

  • EXPANDING INSURER COVERAGE - Co said growth was fueled by expanding reimbursement coverage for SWIFT protocol

  • HIGHER UTILIZATION - Co cited increasing utilization throughout its installed base as a growth driver


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q2 Revenue

$17.11 mln

Q2 EPS

$0.07

Q2 Net Income

$2.71 mln

Q2 Gross Profit

$12.77 mln

Q2 Operating Income

$2.39 mln

Q2 Pretax Profit

$2.92 mln


Analyst Coverage

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 3 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

  • Wall Street's median 12-month price target for Brainsway Ltd is $18.00, about 20.2% above its August 11 closing price of $14.98


Reuters Recommended Reads

  • Aug 11 - Neuronetics Q2 revenue beats estimates on Greenbrook clinic strength

  • Aug 11 - NeuroPace Q2 revenue slightly beats estimates

  • Aug 11 - Stereotaxis Q2 revenue misses estimates, dragged by system decline

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Brainsway

See all news